Consumer Reports Criticize Chantix Advertisement
Date: 19th February 2009
According to a recent revelation, a Pfizer sponsored advertisement of its quit smoking medicine Chantix has reportedly drawn criticism for marketing the product in the guise of a special public service declaration. Consumer reports are raising queries over the legitimacy of the DTC(Direct to consumer) Chantix advertisement that aims at marketing the anti-smoking medication Chantix. However, several consumer reports state that the procedures adapted to publicize the chantix ad are lawful but undertaken in a secret manner.
Such DTC advertisements have increasingly come to be termed as “help-seeking” ads. It is further known that these so-called ads never mention the advertised medicines but only initiate a thorough discussion of the treatment procedure for which the medicine is approved by guiding viewers to a toll-free number or website. In the next step, the toll-free number or the website provides specific information that includes acquiring information on a “prescription treatment option.”
Sources make it apparent that the Chantix advertisement is directly aiming at the site MyTimeToQuit.com and throws light on specific information in a public service model. However, the site MyTimeToQuit.com guides web browsers to the official chantix website of the manufacturer Pfizer Incl. Further, specific consumer reports point out that it is only at the end of the advertisement that the ads origin is revealed secretly.
The FDA (Food and Drugs Administration) states that this type of advertisement is definitely effective when the pharmaceutical industry is looking forward to undertake marketing of a medicine capable of unleashing hazardous side-effects. It is because if the name of the medicine is not enlisted in the advertisement, the advertiser is not specially required to reveal side-effects triggered off by the medicine.
Source: http://www.newsinferno.com/ |
